Related Experiment Video

Updated: Jun 23, 2026

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development
09:32

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development

Published on: June 15, 2017

TAK1 kinase determines TRAIL sensitivity by modulating reactive oxygen species and cIAP

S Morioka1, E Omori, T Kajino

  • 1Department of Molecular Biology, Nagoya University, Japan.

Oncogene
|May 8, 2009
PubMed

Insights

Deleting TAK1 kinase enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) cancer cell death by increasing reactive oxygen species (ROS) and downregulating cIAP. This suggests TAK1 inhibition could improve TRAIL therapy effectiveness.

Area of Science:

  • Molecular Biology
  • Cell Death Pathways
  • Cancer Therapeutics

Background:

  • Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces cancer cell death, but resistance is common.
  • Mechanisms governing TRAIL sensitivity remain largely unknown.
  • TAK1 kinase plays a role in cellular signaling pathways.

Purpose of the Study:

  • To investigate the role of TAK1 kinase in TRAIL-induced apoptosis.
  • To elucidate the molecular mechanisms underlying TRAIL resistance and sensitivity.
  • To explore the potential of targeting TAK1 for enhancing TRAIL-based cancer therapies.

Main Methods:

  • Deletion of TAK1 kinase in various cell types, including keratinocytes, fibroblasts, and cancer cells.
  • Stimulation with TRAIL and assessment of caspase-3 activation and cell death.
  • Analysis of NF-kappaB pathway activation, reactive oxygen species (ROS) levels, and cellular inhibitor of apoptosis protein (cIAP) expression.

Main Results:

  • TAK1 kinase deletion significantly increased caspase-3 activation and cell death upon TRAIL stimulation.
  • TRAIL induced ROS accumulation in TAK1-deleted cells, independent of NF-kappaB pathway modulation.
  • TAK1 deletion led to TRAIL-dependent downregulation of cIAP, enhancing caspase-3 activation.

Conclusions:

  • TAK1 deletion potentiates TRAIL-induced apoptosis by promoting caspase activation via ROS accumulation and cIAP downregulation.
  • Targeting TAK1 kinase represents a promising strategy to overcome TRAIL resistance in cancer treatment.
  • Understanding TAK1's role offers new insights into regulating programmed cell death.

More Related Videos

Visualizing Protein Kinase A Activity In Head-fixed Behaving Mice Using In Vivo Two-photon Fluorescence Lifetime Imaging Microscopy10:41

Visualizing Protein Kinase A Activity In Head-fixed Behaving Mice Using In Vivo Two-photon Fluorescence Lifetime Imaging Microscopy

Published on: June 7, 2019

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...